Drug Formulary Review articles from February 2006

Drug Formulary Review archives from February 2006

Unapproved abbreviations most problematic patient safety goal.
February 1, 2006... Unapproved abbreviations most problematic patient safety goal Read-back of verbal orders also a common challenge for pharmacy Almost half of hospitals trying to be compliant with patient safety goals of the Joint Commission on...

'Pearls' of wisdom about NAC administration.
February 1, 2006... 'Pearls' of wisdom about NAC administration Tolerance most improved using IV formulation A certain soft drink has led the way in tests for masking the taste and smell of oral N-acetylcysteine (NAC) in treating acetaminophen poisoning,...

News Briefs.
February 1, 2006... Preferred treatment for advanced ovarian cancer announced The National Cancer Institute (NCI), part of the National Institutes of Health, has issued an announcement encouraging after-surgery treatment with anticancer drugs through...

New FDA Approvals: New treatment approved for advanced kidney cancer.
February 1, 2006... New treatment approved for advanced kidney cancer Drug doubles progression-free survival The first treatment for advanced renal cell carcinoma has been approved by the FDA in more than a decade. Sorafenib tosylate (Nexavar) is the...

Drug Criteria & Outcomes: Paricalcitol (Zemplar) Formulary Evaluation.
February 1, 2006... Drug Criteria & Outcomes Paricalcitol (Zemplar) Formulary Evaluation By Tim Barclift, PharmD Candidate, Harrison School of Pharmacy, Auburn (AL) University Written while on clinical rotation at Huntsville (AL) Hospital Brand name:...

CE objectives/questions.(continuing education)(Brief Article)
February 1, 2006... CE objectives/questions Pharmacists participate in this continuing education program by reading the article, using the provided references for further research, and studying the CE questions. Participants should select what they believe to...